论文部分内容阅读
目的:分析研究通过钼靶、B超检查对于乳腺癌诊断的临床意义。方法:从2012年12月到2013年12月被我院确诊为乳腺癌患者中随机选取136例病例,以所有患者的钼靶、彩超等医学影像资料以及患者病例诊断作为分析研究对象。结果:病灶直径超过2.0cm(含2.0cm)的85例乳腺癌患者其B超诊断率为84.71%(72/85),钼靶诊断率为82.35%(70/85),两者诊断率不存在统计学差异(p>0.05);肿瘤直径小于2.0cm的51例乳腺癌患者其B超诊断率为74.51%(38/51),钼靶诊断率为68.63%(35/51)。两者诊断率不具有统计学差异(p>0.05)。通过钼靶与B超进行联合检查,总有效率为91.78%(124/136)结论:通过钼靶与彩色B超对于乳腺癌进行检测,各有检测优势与不足,两者检测诊断率无明显差异,而通过钼靶与B超联合检测乳腺癌可有效提高软腺癌诊断率。
OBJECTIVE: To analyze the clinical significance of mammography and B-ultrasound in the diagnosis of breast cancer. Methods: From December 2012 to December 2013, 136 cases were randomly selected from patients diagnosed as breast cancer in our hospital. All patients’ mammography, color Doppler ultrasound and other medical imaging data as well as the diagnosis of patients were analyzed. Results: The diagnostic rates of B ultrasound and ultrasonography in 85 cases of breast cancer with diameter> 2.0cm (including 2.0cm) were 84.71% (72/85) and 82.35% (70/85), respectively. The diagnostic rates of the two (P> 0.05). The diagnostic rate of B-ultrasonography was 74.51% (38/51) in 51 cases of breast cancer with tumor diameter less than 2.0cm, and the diagnostic rate of molybdenum target was 68.63% (35/51). There was no statistical difference between the two diagnostic rates (p> 0.05). The total effective rate was 91.78% (124/136). The detection of breast cancer by molybdenum target and color B ultrasound had their own advantages and disadvantages, the detection rate of the two methods was not obvious Difference, and through the mammography and B ultrasound detection of breast cancer can effectively improve the diagnostic rate of soft adenocarcinoma.